Position in OTLK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$65,029
New position
Shares Held
40,899
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 68 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in OTLK
reported options exposure · as of Jun 30, 2026CallValue
$7,950
CallShares
5,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Belvedere Trading LLC holds $401,074 across 2 Biotechnology names. OTLK ranks #2 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORKA |
Oruka Therapeutics, Inc.
|
3,531 | $336,045 | |
| 2 | OTLK |
Outlook Therapeutics, Inc.
This page
|
40,899 | $65,029 |
All Filings in OTLK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,029 | 40,899 | Shares | Sole | 2026-07-31 | |
| 2026-06-30 | $7,950 | 5,000 | Call | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||